The influence of trait mindfulness on depression in multiple sclerosis: potential implications for treatment.


Journal

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
ISSN: 1573-2649
Titre abrégé: Qual Life Res
Pays: Netherlands
ID NLM: 9210257

Informations de publication

Date de publication:
Dec 2020
Historique:
accepted: 19 06 2020
pubmed: 3 7 2020
medline: 15 12 2020
entrez: 3 7 2020
Statut: ppublish

Résumé

This study seeks to add to existing literature on depression and illness intrusiveness in chronic disorders by examining, (1) how the perceived intrusiveness of multiple sclerosis (MS) leads to depression, (2) and the mediating role trait mindfulness plays in this relationship METHODS: Participants (N = 755) were persons with MS (PwMS) recruited through the North American Research Committee on MS (NARCOMS) registry (a larger study). Participants completed the Illness Intrusiveness Ratings Scale, the Hospital Anxiety and Depression Scale and the Mindful Attention Awareness Scale. A mediation model assessed if trait mindfulness mediates the relationship between illness intrusiveness and depression RESULTS: Illness intrusiveness predicted trait mindfulness (a =  - 4.54; p < .001), trait mindfulness predicted depression (b =  - .04; p < .001); there was a direct effect of illness intrusiveness on depression (c' = 2.53; p < .001) and an indirect effect on depression (ab = .17, 95% BCa CI [.10, .25]) when trait mindfulness was in the model, which represented a medium size effect, R

Identifiants

pubmed: 32613306
doi: 10.1007/s11136-020-02567-6
pii: 10.1007/s11136-020-02567-6
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3243-3250

Auteurs

Jennifer R Miller (JR)

Ferkauf Graduate School of Psychology, Yeshiva University, 1165 Morris Park Ave., Bronx, NY, 10461, USA. jrmiller@mail.yu.edu.

Caroline Altaras (C)

Ferkauf Graduate School of Psychology, Yeshiva University, 1165 Morris Park Ave., Bronx, NY, 10461, USA.

Nicholas A Vissicchio (NA)

Ferkauf Graduate School of Psychology, Yeshiva University, 1165 Morris Park Ave., Bronx, NY, 10461, USA.

Vance Zemon (V)

Ferkauf Graduate School of Psychology, Yeshiva University, 1165 Morris Park Ave., Bronx, NY, 10461, USA.

Jeffrey G Portnoy (JG)

Ferkauf Graduate School of Psychology, Yeshiva University, 1165 Morris Park Ave., Bronx, NY, 10461, USA.

Elizabeth S Gromisch (ES)

Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, 490 Blue Hills Avenue, Hartford, CT, 06112, USA.
Department of Neurology, University of Connecticut School of Medicine, Farmington, CT, USA.
Department of Rehabilitative Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, USA.
Department of Medical Sciences, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, USA.

Jessica Sloan (J)

Rocky Mountain Regional Veterans Affairs Medical Center, 1700 N Wheeling St, Aurora, CO, 80045, USA.

Tuula Tyry (T)

Dignity Health, St. Joseph's Hospital and Medical Center, 350 W Thomas Road, Phoenix, AZ, 85013, USA.

Frederick W Foley (FW)

Ferkauf Graduate School of Psychology, Yeshiva University, 1165 Morris Park Ave., Bronx, NY, 10461, USA.
Holy Name Medical Center Multiple Sclerosis Center, Teaneck, NJ, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH